Lilly Advances Bill to Increase Transparency in Prescription Drug Costs

SPRINGFIELD, Ill. – In an effort to improve affordability and clarity in healthcare pricing, state Rep. Camille Y. Lilly, D-Chicago, is celebrating the advancement of legislation out of committee that aims to increase fairness and transparency in how prescription drug costs are determined.

“Prices for Illinoisans to go to the hospital or pick up their prescriptions are already too high,” Lilly said. “It becomes even more concerning when they are not receiving full credit for what they are already paying. That’s why I am pushing this bill, to ensure that those payments are recognized.”

House Bill 2680 would require health insurance plans that cover prescription drugs to count all payments made toward a patient’s medications, whether paid directly by the patient or on their behalf, when calculating out-of-pocket maximums and other cost-sharing limits. Starting Jan. 1, 2027, any new, renewed, or updated plans would need to include these payments in their calculations, with an exception for high-deductible health plans if doing so would make them ineligible for a Health Savings Account. 

Lilly has been a strong advocate for affordable healthcare and protections against unexpected medical costs. This legislation continues her efforts to ensure fair treatment for Illinois residents.

“This measure will help reduce financial strain on patients managing chronic conditions and improve transparency in how insurance benefits are applied,” Lilly said. “I look forward to working with my colleagues to advance this measure.” 

The bill moves to the House for further consideration.